Image source: NbryoQueensland agritech company Nbryo has secured $10 million in funding to double down on its bovine reproductive technologies that can reduce seven years of selective cattle breeding into a week.
The seed raise, led by existing investor Tenacious Ventures alongside QIC Ventures and New Zealand–based AgriZero, allows the company to advance its core technology roadmap and scale operations from Queensland.
Born from 15 years of research on a cattle property near Beaudesert, Nbryo’s in vitro embryo production (IVP) technology is breaking down barriers to advanced cattle breeding techniques for beef and dairy producers globally.
Reducing the cost of an IVP pregnancy by up to 76 per cent brings the economics in line with artificial insemination or natural mating, helping producers achieve rapid genetic advancements to meet growing global demand for efficient and sustainable livestock production.
QIC Ventures Associate Hayden Wall said the investment aligned with Queensland’s growing reputation as a global leader in agricultural technology and innovation.
Nbryo brings the best of agriculture and innovation together to solve one of the cattle industry’s biggest bottlenecks - affordable access to superior genetics.
Hayden Wall - QIC Ventures Associate
“Genetic gain is one of the most powerful levers for reducing the environmental footprint of livestock, and this technology accelerates progress from years to days.
“The company is also backed by an exceptional network of investors and collaborators like the Gates Foundation, whose ongoing support provides strong validation of Nbryo’s platform.
“Coupled with scientific depth and strong Queensland roots, Nbryo is building exactly the type of category-defining, disruptive innovation QIC Ventures is proud to invest in.”
Nbryo CEO Paul Niven said the investment underscores the growing recognition of Nbryo’s potential to deliver solutions at the intersection of biotechnology and digital agriculture.
This capital raising provides the resources we need to accelerate delivery of our technology platform and expand our impact in livestock reproduction.
Paul Niven - Nbryo CEO
By democratising access to high-quality embryos, we believe we can transform cattle breeding efficiency and sustainability worldwide, with a number of trials already underway across Australia, New Zealand and Europe.
“With the support of our investors and the Queensland Government, we have a real opportunity to build a global high-tech business here in Queensland that changes the face of beef and dairy industries everywhere.”
Last year, Nbryo received investment through the QIC-managed Venture Capital Development Fund (VCDF) from Brisbane-based Agrifoods investor, Mandalay Venture Partners.
Nbryo, along with its research partners, has also received over $18 million in grant funding for research and development from the Gates Foundation, Meat and Livestock Australia and other state and federal programs.
For further information, please contact:
Investing from seed to Series C, QIC Ventures has partnered with more than 90 world-class companies taking Australian innovation global since 2016, including Go1, Gilmour Space and VALD. It sits within the institutional QIC Private Equity platform, which manages A$10 billion globally in private equity assets from offices in the US, Europe and Australia.
Nbryo is an Australian agri-biotech company developing next-generation solutions in bovine reproductive technologies. Its integrated IVF platform combines biotechnology with digital tools to deliver scalable, efficient, and high-quality outcomes for cattle producers worldwide.